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An Abstract of the Scholarly Project by  
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The purpose of this study was to determine if follow up visits at the AdventHealth 
Heart Failure Clinic in Shawnee Mission, Kansas were effective in reducing the 30-day 
readmission rate of heart failure patients.   It was also to determine if a patient’s BMI, EF, 
GFR, and A1c would improve or remain stable with follow-up appointments at the same 
clinic or if they would worsen.  The author assessed this through a retrospective chart 
review and collection of data.  Data was collected on the 30-day readmission rate of heart 
failure patients prior to the opening of the clinic in the fall of 2015 and compared to the 
30-day readmission rate of patients who followed up at the clinic after a hospitalization 
for heart failure.  Data was also collected on the EF, GFR, hemoglobin A1c, and BMI 
pre-clinic and compared to the data post-clinic.  The population sampled include 58 
males and 42 females with a current age range of 41 to 99.  Findings showed that not 
only were the 30-day hospital readmissions reduced after the initiation of the 
AdventHealth heart failure clinic; the patients had a lower BMI and increased EF after 
following up and the heart failure clinic when compared to their BMI and EF before the 
opening of the clinic.  These variables demonstrated that the heart failure clinic helped to 
improve the patient outcomes.   Future studies should be completed to include larger 
sample sizes and include variables such as race, medication compliance, and diet 
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Heart failure is a common disease affecting over 5 million people (Centrella-
Nigro et al., 2016).  It has high morbidity and mortality rates (Bakal, McAlister, Liu, & 
Ezekowitz, 2014).  Heart failure can be acute or chronic and occurs when the heart 
weakens and cannot pump (systolic heart failure) or stiffens and cannot fill (diastolic 
heart failure).  Both types of heart failure prevent the heart from effectively pumping 
blood (“What is Heart Failure?”, n.d.).  When the blood cannot be effectively pumped, it 
backs up causing congestion and fluid overload (“What is Heart Failure?”, n.d.).  The 
weakened heart muscle is also unable to effectively perfuse the tissues of the body 
(Centrella-Nigro et al., 2016).  Heart failure is characterized by an abnormal functioning 
heart that causes frequent hospital admissions, poor exercise tolerance, reduced quality of 
life, a shortened life expectancy, and an overall poor prognosis (Wijeysundera et al., 
2012).  Heart failure is not only a major problem but one that continues to increase in 
numbers.  Over that last 25 years, hospitalizations have increased from approximately 
800,000 annually to over 1 million with heart failure as the primary diagnosis (Kim & 
Han, 2013).  That number increases if you add in patients hospitalized with heart failure 
as a secondary diagnosis (Kim & Han, 2013).   
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An estimated 5.7 million people in the United States have heart failure and 
approximately 670,000 people are newly diagnosed with heart failure each year 
(Centrella-Nigro et al., 2016). Over one million people are admitted to hospitals each 
year with heart failure; at least one-fourth of these patients will be re-admitted within 
thirty days of discharge for the same reason (Centrella-Nigro et al., 2016).  Regardless of 
advances in technology and treatment therapies, only about half of patients diagnosed 
with heart failure survive more than five years after their initial diagnosis (Kovell, 
Juraschek, & Russell, 2015).  The cost is high not only in terms of human health and life.  
Financially, in 2013 alone, the estimated cost of heart failure was $32 billion and is 
predicted to cost Americans $70 billion by 2030 (Kovell et al., 2015).   
Heart failure is, in fact, the most expensive disease related diagnosis in the United 
States with five million hospital stays each year at a cost of approximately $8 billion 
(Sperry, Ruiz, & Najjar, 2014).  Due to the Affordable Care Act’s Readmission Reduction 
Program, Medicare now decreases payments to the hospital based on the hospital’s 
readmission performance (Sperry et al., 2014).  Heart failure is the most common cause 
of hospital readmissions with nearly 20% of Medicare patients being readmitted within 
30 days with heart failure exacerbations (Sperry et al., 2014).  The average 90-day 
readmission rate of heart failure patients is about 15-30%, and it is estimated that 90% of 
those readmissions are potentially preventable (McClintock, Mose, & Smith, 2014).  
These potentially preventable readmissions end up costing about $17 billion in healthcare 
costs (McClintock, Mose, & Smith, 2014).  Even with the decrease in reimbursement and 
the poor patient outcomes, not much has been done to successfully reduce the 
readmission rate for heart failure patients.  Early follow up visits at heart failure clinics 
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after a hospitalization for heart failure could be the foundation to reducing the 
readmission rate of these patients.   
Description of the Clinical Problem 
Heart failure is the number one cause for hospitalization and has the highest 
related healthcare costs in the United States (Feltner et al., 2014).  A review of Medicare 
claims from 2007 to 2009 showed that 35% of all 30-day hospital readmissions were for 
heart failure (Feltner et al., 2014).  Heart failure has many causes and comorbidities that 
can worsen the disease or make it more difficult to treat.  A diagnosis of heart failure is 
made by performing an echocardiogram to estimate the EF, obtaining a chest x-ray, or by 
blood work to look at biomarkers such as the pro-BNP (Yancey et al., 2013).  Once a 
patient has been diagnosed with heart failure, they must be educated on the lifestyle and 
medication changes to encourage compliance.  Heart failure patients need to follow a low 
sodium (less than 2000 mg per day), exercise daily, and obtain daily weights (Shawnee 
Mission Health Heart & Vascular Center, 2015).   
There are many different medications used to control heart failure and prevent 
exacerbations.  Beta blockers, such as metoprolol and carvedilol, reduce the morbidity 
and mortality rate as well as the rate of sudden cardiac death in heart failure patients (Al-
Gobari, El Khatib, Pillon, & Gueyffier, 2013).  Diuretics are used to remove excess fluid 
and prevent fluid overload and can also be used in acute exacerbations at higher doses.  
There are many diuretics to choose from when deciding on a treatment plan with the most 
common one being furosemide or Lasix (Houston, Kalathiya, Kim, & Zakaria, 2015).  
Other diuretic classes include thiazide diuretics, with one example being 
hydrochlorothiazide; aldosterone antagonists, such as spironolactone, which is a 
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potassium sparing diuretic; and vasopressin antagonists, such as tolvaptan (Houston et al., 
2015).  Blood pressure control is done with angiotensin-converting enzyme (ACE) 
inhibitors such as Lisinopril and angiotensin II receptor blockers (ARB) such as losartan 
(Yancey et al., 2013). 
Symptoms of an exacerbation include increased shortness of breath; orthopnea, 
which is shortness of breath while lying down; dry cough; edema of the legs, ankles, feet, 
or abdomen; unexplained or increased weakness or fatigue; wheezing; abdominal pain or 
loss of appetite; and/or sudden weight gain of two to three pounds in one day or greater 
than five pounds in one week (Shawnee Mission Health Heart & Vascular Center, 2015).  
Diet modifications, lifestyle changes, and medications are used to prevent acute 
exacerbations and hopefully prevent hospitalizations, re-admissions, and increase the 
lifespan of the patient.     
The best way to reduce readmissions for heart failure is to prevent heart failure in 
the first place.  Prevention of heart failure begins with reducing the risk factors that cause 
heart failure and may start with the primary care provider.  The primary care provider 
must know the risk factors for heart failure and routinely screen patients with these risk 
factors.  Patients without heart failure symptoms or an official heart failure diagnosis but 
currently have comorbidities that put them at risk for heart disease such as diabetes 
mellitus, obesity, coronary heart disease, hypertension, or chronic kidney disease are said 
to have stage A heart failure (Kovell et al., 2015).  Stage A heart failure is defined as 
having a predisposition for heart failure but without any structural heart disease or heart 
failure symptoms (Kovell et al., 2015).  There are four stages of heart failure, with stage 
A being the first.  To prevent the progression of stage A heart failure to stages where 
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structural damage occurs or heart failure symptoms occur (stages B, C, or D), primary 
care providers need to work with patients on aggressive risk factor control.  This includes 
sodium intake of less than 2000 mg per day, a BMI less than 30 kg/m2, low density 
lipoprotein less than 100 mg/dL or an even lower goal of less than 70 mg/dL, hemoglobin 
A1c of less than 7%, systolic blood pressure less than 140 mm Hg, and diastolic blood 
pressure less than 90 mm Hg (Kovell et al., 2015).  This should be the goal for prevention 
in patients with comorbidities that put them at higher risk for developing heart failure. 
Since prevention is not an option for the over five million people in the United 
States who currently have heart failure, other methods to reduce readmissions must be 
found.  Education needs to be provided to help reduce the number of exacerbations and 
hospitalizations and needs to be introduced at the initial diagnosis and continued in the 
primary care setting.  Patients need to be educated on the diet to follow, activity 
recommendations with any restrictions, symptoms to watch for and symptoms to report, 
and medications.  Patients not only need to know what medications they are taking but 
why they are taking them.  Heart failure clinics could provide the perfect setting for this 
education.  During hospitalizations for heart failure, patients are provided education by 
the nurses.  However, questions often arise once the patient has been discharged, and a 
follow up appointment within a week of discharge could provide the optimal setting for 
those questions to be answered.  These clinics could also provide a platform for further 
education to ensure the patients understand the changes that must be made to obtain the 
best possible outcomes, as well as what will happen if these changes are not made.     
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Significance to Nursing 
The establishment of heart failure clinics is one method used to try to reduce the 
readmission rate of heart failure patients and reduce the healthcare costs associated with 
these readmissions.  Many studies have shown that the key to reducing readmissions is 
regular follow ups with medical professionals; whether it be home based, clinic based, 
telemonitoring, or primary care follow ups.  Patients who follow up within 7 to 14 days 
after discharge from a hospital had significantly lower rates of readmissions within 30 
days (Jackevicius, et al., 2015).  Another important factor in reducing the readmission 
rate is patient centered education and strategies for reducing their readmissions.  The 
“one size fits all” method currently used in many hospitals doesn’t work for most 
patients.  In order to help heart failure patients become more engaged in their health 
management and self-care, they need to have the education centered around their needs.  
The standard guidelines for education currently required should still be provided to 
patients; however, patients felt more empowered to overcome their illness and more well-
prepared when their education was tailored around their needs (Ross, Ohlsson, Blomberg, 
& Gustafsson, 2015).  Compliance with medications, diet restrictions, fluid restrictions, 
exercise and activity requirements, daily weight monitoring, and keeping their follow up 
appointments is key to reducing readmissions for heart failure.  Patient engagement is the 
key to compliance.  If patients aren’t engaged in their self-care, they will be less likely to 
see the need for compliance and have poor outcomes (Ross et al., 2015).   
Theoretical Framework 
The Uncertainty in Illness Theory and Uncertainty in Illness Scales by Merle 
Mishel were developed to measure the perceived uncertainty felt by chronically and 
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acutely ill patients, family members of these patients, and caregivers of the patients.  This 
theory and associated scales can be used to assess if the uncertainty in the illness is 
perceived as a threat or as an opportunity.  If it is viewed as a threat, patients try to 
decrease the uncertainty by learning as much as they can about the illness.  If the illness 
is viewed as an opportunity, it becomes a normal part of the everyday life and the patient 
tries to maintain the uncertainty (Alligood, 2014).  Much of the literature reviewed based 
the patient interventions on techniques to lessen the uncertainty faced by patients with 
heart failure.  This was done in many studies with patient centered education and 
strategies to increase patient engagement and interest in self-care.  The more engaged and 
involved patients are with their own health, the better the outcomes may be.      
      
Figure 1.  Mishel’s Uncertainty in Illness Theoretical Framework (Alligood, 2014). 
The figure above shows Mishel’s Uncertainty in Illness Theoretical Framework.  
The Stimuli frame represents the disease or illness.  This causes uncertainty.  
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Subsequently, the patient decides if they will view this as a positive (opportunity) or a 
negative (danger), and they adapt their lives based on the inference they make.  The 
cognitive capacities and structure providers are interventions that aim to decrease 
uncertainty.  These interventions to lessen the uncertainty felt by heart failure patients 
could be some of the interventions from the articles discussed in the literature review 
found in Chapter 2.  The major interventions being patient-centered education and 
patient-centered care.     
Purpose and Objectives 
 The purpose of this scholarly project was to determine if follow up visits at the 
AdventHealth Heart Failure Clinic in Shawnee Mission, Kansas were effective in 
reducing the 30-day readmission rate of heart failure patients.  When patients are 
discharged from the hospital for a heart failure related admission, they are educated on 
the need to follow up with their primary care provider within seven to ten days after 
discharge.  Occasionally these appointments are made prior to discharge; however, 
patient follow through is not guaranteed or monitored.  The AdventHealth Heart Failure 
Clinic ensures that patients admitted for heart failure or with a heart failure related 
diagnosis are scheduled for an appointment within one week of discharge at the nurse 
practitioner led heart failure clinic.  These appointments are monitored for follow through 
and patients are provided the individualized education needed.  This study was designed 
to ascertain whether these appointments were effective in reducing the number of heart 
failure related readmissions and improving patient outcomes.    
Project Questions 
The project questions this study will attempt to answer are as follows:   
9 
 
1. Did patients who received care at a heart failure clinic have reduced 30-day 
readmission rates versus those who did not receive care at a heart failure 
clinic? 
2. Did patient’s EF, hemoglobin A1c, glomerular filtration rate (GFR), and body 
mass index (BMI) remain stable or improve as a result of heart failure clinic 
visits? 
 
Definition of Key Terms 
The definitions of key terms and variables include heart failure, primary care 
provider, cardiologist, nurse practitioner, heart failure clinic, compliance, ejection 
fraction (EF), pro-BNP, clinical practice guidelines, exacerbation, and readmission.     
Primary Care Provider – a healthcare provider (such as a general practitioner, 
pediatrician, or nurse) who provides health care, with whom a patient has initial 
contact and by whom the patient may be referred to a specialist (Merriam-Webster 
dictionary, n.d.). 
Cardiologist – a physician who specializes in the study of the heart (Yancy, et al., 
2013). 
Nurse Practitioner – advanced practiced registered nurse (APRN) “a registered 
nurse who through advanced training is qualified to assume some of the duties 




Heart Failure Clinic – a clinic that specializes in the treatment of patients with 
heart failure and management of their medications and other needs (Lu, et al., 
2017).  
Compliance – Adhering to a treatment plan (McClintock et al., 2014.). 
Ejection Fraction (EF) – a measure of the percentage of blood ejected during 
systole in relation to the total end-diastolic volume (Srichai, Danias, & Lima, 
2019).    
Pro-BNP – (B-type natriuretic peptide) useful to support clinical judgment for the 
diagnosis or exclusion of heart failure (Yancey, et al., 2013). 
Clinical Practice Guideline –  “statements that include recommendations 
intended to optimize patient care” ("Clinical Practice Guideline Manual", 2017). 
Exacerbation – a worsening of a disease or its symptoms (Merriam-Webster 
dictionary, n.d.). 
Readmission – to be admitted again for the same reason (Sperry, et al., 2014). 
Logic Model 
The logic model for this scholarly project was created to show the relationships 
between the inputs, outputs, and outcomes as well as the assumptions and external factors 
involved in this study.  This logic model, as shown in Figure 2, identifies the short-term, 
intermediate, and long-term outcomes for the project and acknowledges the assumptions 
and external factors influencing the project.   
The inputs of the logic model for this study were this DNP student, nurse 
practitioners, physicians, the AdventHealth heart failure clinic, time, and the research 
performed.  The output activities included consent for participation, review of charts to 
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determine the readmission rates before the opening of the heart failure clinic as well as 
review of the charts to determine the readmission rate after the heart failure clinic 
opened.  Participation was needed from the heart failure clinic, nurse practitioners, and 
this DNP student.   
The short-term outcomes of this study were an increased knowledge of the heart 
failure clinical practice guidelines and a better understanding of heart failure and what is 
needed to prevent readmissions.  The intermediate outcomes of this study were an 
increase in the referrals to heart failure clinics and an increase in the medication and 
lifestyle compliance with heart failure patients.  The long-term outcomes of this study 
were a decrease in heart failure related readmissions and a decrease in the morbidity and 
mortality of heart failure patients.   
The assumptions were that consent would be given for the review of charts by the 
clinic, the charts reviewed would provide an accurate sampling reflecting the overall 
patient population, and the heart failure clinic would be found to reduce the readmission 
rate of heart failure patients.  The external factors would be patient compliance with their 
medications and necessary lifestyle changes as well as their understanding of heart failure 









Project:  Heart Failure Clinic Logic Model 
Goal:  To determine the effectiveness of heart failure clinics in reducing the readmission 
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Figure 2.  Logic Model – Effectiveness of Heart Failure Clinics on Reducing Hospital 
Readmissions 
Assumptions 
Consent will be given for chart review 
Patient charts reviewed will be an 
accurate sampling to reflect the overall 
patient population 
Heart failure clinics will be found to 
help reduce the readmission rate of 
heart failure patients 
 External Factors 
Patient compliance with medications 
and lifestyle changes 
Patient understanding of heart failure 





Heart failure is the main illness-related cause of hospitalization and over five 
million Americans have this diagnosis (McClintock et al., 2014).  Education needs to start 
at the initial diagnosis and continue in primary care or heart failure clinic settings.  
Patients should have a discussion with their health care provider about what their 
education needs are and what they need to learn to be successful and compliant in 
maintaining their health.  Finally, patients need to be educated on what is necessary to 
manage their health including monitoring their daily weights and blood pressures.  Heart 
failure clinics provide an excellent location for patients to be given this individualized 
education.  These interventions all combined should help decrease the readmission rates 

















Review of the Literature 
 
 
This review of the literature provides an overview of the research to date on what 
can be done to reduce the readmissions for heart failure patients and on the role of patient 
involvement in heart failure clinics as a major factor in reducing the rate of readmissions.  
It further reviews the interventions that have been associated with decreased morbidity, 
mortality, and hospitalizations in heart failure patients.  The purpose of this literature 
review is to use the research to determine the underlying cause of readmissions in heart 
failure patients, find common themes in the literature on how to reduce readmissions, and 
determine if patient involvement in heart failure clinics is beneficial in reducing the 
readmission rate of heart failure patients.   
A systematic search of the literature was performed using the electronic databases 
SUMMONS and ProQuest Nursing & Allied Health Source.  The key terms used to 
gather data for this review of the literature were “Heart failure clinics” AND 
“Readmissions.”  Reducing the readmission rate in heart failure patients was the primary 
concept reviewed in this synthesis.  The concepts of heart failure clinics, education, 
compliance, and other interventions to reduce the readmission rate of heart failure 
patients were reviewed to identify what is known concerning each concept and how they 
apply to the primary concept.  Common themes were found and areas where more 
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research is needed were identified.  Many of the research studies found on reducing the 
readmission rates in heart failure patients were quantitative in nature and used statistics to 
determine if the quality improvement initiative was beneficial in reducing the 
readmission rate in heart failure patients.  The two qualitative studies found were 
conducted in Sweden however both provided excellent interventions that are applicable 
in the United States.    
Definition of Heart Failure  
 Heart failure as defined by the 2013 ACCF/AHA Heart Failure Guidelines as “a 
complex clinical syndrome that results from any structural or functional impairment of 
ventricular filling or ejection of blood” (Yancy, et al., 2013, p. e246).  The weakened 
heart muscle is also unable to effectively perfuse the tissues of the body (Centrella-Nigro 
et al., 2016).  The common symptoms of heart failure are fluid retention, edema, dyspnea, 
and/or fatigue (Yancy, et al., 2013).  Heart failure is characterized by an abnormal 
functioning heart that causes frequent hospital admissions, poor exercise tolerance, 
reduced quality of life, a shortened life expectancy, and an overall poor prognosis 
(Wijeysundera et al., 2012).   
 A thorough history and physical is needed to determine possible causes of heart 
failure or diseases that may accelerate or worsen existing heart failure (Yancy, et al., 
2013).  Laboratory orders for a complete blood count (CBC), urinalysis, serum 
electrolytes, blood urea nitrogen (BUN), serum creatinine, fasting lipid profile, 
hemoglobin A1c, and pro-B-type natriuretic 
peptide (pro-BNP) should be obtained (Yancy, et al., 2013).  The diagnostic imaging 
needed for each patient to diagnose heart failure are a chest x-ray to determine 
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approximate heart size and if there is any pulmonary congestion present, and 
echocardiogram to determine EF, ventricular function, wall thickness, and valve function 
(Yancy, et al., 2013).   While the diagnosis of heart failure is mainly a clinical diagnosis 
based on a thorough history and physical combined with patient symptoms, these 
diagnostic tests and labs help to classify the stage of heart failure (Yancy, et al., 2013).   
Patient Centered Care  
Patient centered care was a common theme in the studies on reducing the 
readmission rate of heart failure patients.  Current practice in hospitals is to educate 
patients based on what is known regarding best practice for the prevention of heart failure 
exacerbations.  The education is the same for every patient on every admission.  Ross et 
al. (2015) explains how patient centered education was used to increase patient 
engagement as well as increase their involvement in the self-care practices necessary for 
maintaining health and preventing readmissions.  The study asked the patient to write 
down their questions at the beginning of their diagnosis of heart failure so the education 
could be tailored to their individual perceived needs.  By doing this, the patients stated 
they felt more empowered.  If patients are not engaged in their self-care, they will be less 
likely to see the need for compliance and have poor outcomes (Ross et al., 2015).  
Although current best practices for patient education needs to be provided, patients were 
found to feel more empowered to overcome their illness and better prepared to fight the 
disease when their education was tailored to meet the patients’ own perceived needs. 
(Ross et al., 2015).   
A review of data collected by Sperry, Ruiz, and Najjar (2014) took patient 
cognition, finances, quality of life, and the presence of depression into consideration to 
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reduce the readmission rate of heart failure patients.  They found that by screening for 
deficiencies in each of these areas, patient education can be more focused on the 
interventions specifically needed by the patient to improve health outcomes and decrease 
readmissions (Sperry et al., 2014).  Increased hospital admissions correlate with a greater 
functional decline in the patient which can make them less capable of caring for 
themselves, less compliant with keeping follow up appointments and monitoring daily 
weights, and unable to comply with everything needed to manage their heart failure 
(Sperry et al., 2014).  These patients would need assistance in purchasing their 
medications, planning and carrying out low budget meal ideas that follow the heart 
failure low sodium diet guidelines, and would need personalized education that fits their 
cognitive level.  Without this added assistance, the patients are at a greater risk for 
readmission which then leads to further decline (Sperry et al., 2014).   
The use of depression screens during the initial hospitalization and diagnosis of 
heart failure was one patient centered intervention used to decrease readmission rates in 
heart failure patients (Lea, 2014).  The many symptoms of heart failure, increased 
weakness, and feelings of uncertainty caused by the diagnosis put the patient at a high 
risk for developing depression (Sperry et al., 2014).  Depression is associated with 
increased mortality and poor overall outcomes.  Readmission rates of those with major 
depression are four times higher than those with no depression or mild depression (Lea, 
2014).    
Early Follow-up Care   
Early follow-up care after a hospitalization was found to be a key component in 
reducing the rate of readmissions in heart failure patients (McClintock et al., 2014).  
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When patients are discharged home from a hospitalization, they are to follow up with 
their primary care provider within 7-14 days with the emphasis being on seven days.  The 
American College of Cardiology and the National Institute for Healthcare Improvement 
launched the quality improvement initiative, The Hospital to Home, in March 2011 
(McClintock et al., 2014).  This initiative introduced “See You in 7” which focused on 
early follow up care (McClintock et al., 2014).  This early follow up care is to lower the 
risk for readmission (McClintock et al., 2014).  The study done by Jackevicius et al. 
(2015) showed that among the 277 total patients studied, 23.3% of the control group 
patients were readmitted to the hospital within 90 days and only 7.6% of the clinic 
patients were readmitted to the hospital within 90 days.  The most important finding was 
that early follow-up care was received by the heart failure patients, whether it be at a 
heart failure clinic or at a health care provider’s office (Feltner et al., 2014).  Andersson, 
Eriksson, and Nordgren (2013) did a qualitative study that combined the themes of 
patient centered care and regular follow ups with a health care professional.  They found 
that personalizing the early follow up care to the individual patients caused better patient 
satisfaction as well as better patient outcomes.  Stewart et al. (2012) found 67% of the 
home-based care patients compared to 69% of the clinic-based care patients had greater 
than or equal to one unplanned hospitalization.  The main difference between home-based 
care and heart failure clinic-based care was home-based had lower associated costs.  Both 
interventions had reduced readmission rates however, home-based interventions reduced 
health care costs by about one-third (Stewart et al., 2012).    
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Heart Failure Clinics and Readmission Rates   
The establishment of heart failure clinics is one method used to try to reduce the 
readmission rate of heart failure patients.  Pharmacist-managed medication titration 
clinics were looked at in the study by Martinez, Saef, Paszczuk, and Bhatt-Chugani 
(2013) to see if these clinics reduce the readmission rate.  The outcome of this study was 
that patients were more likely to achieve optimal doses of their angiotensin-receptor 
blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs), and beta blockers.  
However, there was no statistically significant correlation between participation in these 
clinics and decreased readmissions (Martinez, Saef, Paszczuk, & Bhatt-Chugani, 2013).   
Patient involvement in heart failure clinics is thought to help reduce the rate of 
readmissions in heart failure patients, and many studies have been carried out on this 
assumption.  Results, however, vary.  One study done in Ontario, Canada, found 
involvement in heart failure clinics did seem to decrease the readmission rate, yet critics 
of the study believe there is a need to standardize the care provided in these clinics for the 
results to be valid (Wijeysundera et al., 2012).  When looking at the research, it is 
impossible to compare the results confidently due to the difference in how the clinics are 
set up and the interventions they provide.  The study by Jeckevicius et al. (2015) 
specifically looked at the involvement in heart failure clinics and reduction of 
readmissions and found that the clinics in their study were associated with a significant 
reduction in the 90-day readmission rate for heart failure patients.  They also found 
follow up care at a heart failure clinic within 7-14 days of discharge from a hospital 
significantly reduced the 30-day readmission rate for heart failure patients (Jackevicius et 
al., 2015).  This shows a positive relationship between early follow-up care and 
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involvement in a heart failure clinic in reducing the patient’s risk for readmission.  This 
study, however, was an observational study and may have had a biased selection of 
participants (Jackevicius et al., 2015).   
The study by Kutzleb et al. (2015) looked at the effects on rehospitalization from 
the use of a nurse practitioner-led heart failure clinic that targeted the causes of 
rehospitalization in heart failure patients.  These were listed as “lifestyle, medication and 
diet noncompliance, and lack of self-care disease management” (Kutzleb et al., 2015, p. 
302).  Not only did the 30-day readmission rate decrease, but there was found to be an 
increase in patient engagement, self-management, and compliance (Kutzleb et al., 2015).  
Lu et al. (2017) showed a significant increase in heart failure related medication 
compliance with involvement in specialized multidisciplinary heart failure clinics.  These 
clinic appointments were with physician assistants, pharmacists, and case managers.  At 
90 days post discharge, clinic patients were 86% compliant with twice daily Beta 
blockers versus 66% compliant in the control groups.  Patients in the clinic group also 
had a significantly higher rate of medication compliance with aldosterone antagonists, 
ACE inhibitors, angiotensin II receptor blockers, and digoxin (Lu et al., 2017).   
Martinez et al. (2013) performed a study to determine if a pharmacist-managed 
heart failure medication titration clinic decreased the readmission rate of patients with 
heart failure.  Current heart failure management guidelines recommend the use of 
angiotensin-receptor blockers (ARBs), angiotensin-converting enzyme inhibitors 
(ACEIs), and beta blockers in all heart failure patients (Martinez et al., 2013).  These 
medications need to be titrated in patients to achieve the optimal dose or the highest 
tolerated dose for each patient.  Many times, patients are initiated on the standard starting 
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dose and never titrated above that dose.  With a pharmacist-managed clinic, the 
percentage of patients who reached the optimal dose of each medication was increased 
(Martinez et al., 2013).  This study suggested very promising data; however, it was a 
small-scale trial that was not blind and was therefore not generalizable.  The study was 
performed at Veterans Affairs (VA) medical centers and the majority of the participants 
were white males (Martinez et al., 2013).      
Clinical Practice Guideline   
The heart failure clinical practice guideline was taken from the University of 
Michigan Guidelines for Clinical Care.  The guideline is titled “Heart Failure – Systolic 
Dysfunction” and was last updated in 2013.  Minor revisions were made in December of 
2016 (University of Michigan Health System, 2016).  The following recommendations of 
the heart failure clinical practice guideline are to be used when treating heart failure 
patients to help achieve the best patient outcomes and prevent readmissions.  While this 
is the standard of care, there may be instances where there are contraindications to the 
treatments.  Contraindications will be documented in the electronic medical records by 
the physicians to maintain compliance.  The recommendations are compiled into the 
bundle below.  This bundle has three “steps.”  The recommendations are shown in these 
three “steps” Table 1 below.  Following these three steps together provides a new 








Table 1:  Recommendations with Steps 
    
The practice change recommendations in the clinical practice guideline are not a 
“one size fits all” package that can be used for all heart failure patients.  There are 
specific requirements that come with many of the recommendations as well as 
contraindications patients may have. While there are specific criteria that should be 
considered when trying to apply this bundle to individual heart failure patients, it 
provides an overall standard of how providers should manage and treat heart failure 
patients.  Having a standard of care will help ensure that all patients are getting the best 
care possible.  With the implementation of this CPG for the treatment and management of 
4.  Placed on a Beta blocker (unless contraindicated).  
5.  Placed on a diuretic to maintain fluid balance (either with a loop diuretic or 
an aldosterone antagonist, occasionally both; unless contraindicated).  
6.  Digoxin for patients in Atrial Fibrillation who need rate control, or patients 
who remain symptomatic despite treatment with ACE inhibitors, diuretics, and 
beta blockers (unless contraindicated).  
Device Therapy
7.  Implantable defibrillators should be considered to prevent sudden cardiac 
death in patients with an EF of less than 35%, and bi-ventricular pacemakers 
considered for patients needing defibrillators who have symptomatic heart 
failure and a bundle branch block.  
Recommendations
Diagnosis of Heart Failure
1.  All patients admitted for heart failure need to have an echocardiogram to 
determine their ejection fraction (EF) to diagnose the cause of their heart failure 
(systolic or diastolic dysfunction). 
2.  Upon admission, a serum BNP should be obtained to help determine if the 
dyspnea is heart failure related.  
Pharmacological Therapy
3.  Placed on an ACE inhibitor, ARB, or ARNI (unless contraindicated). 
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heart failure, the life expectancy of heart failure patients should be increased to more than 
five years from the first onset of symptoms as well as decrease the number of 
hospitalizations each year for heart failure exacerbations (University of Michigan Health 
System, 2013). 
Summary 
The survey of the literature shows that patient centered care and education, as 
well as early follow up care after a hospitalization, are important in reducing the 
readmission rate of heart failure patients.  Finding out what the patient wants to know 
regarding their diagnosis, medications, and self-care needs helps to improve patient 
engagement and empowerment.  This, in turn, helps improve patient outcomes and 
decreases readmissions.  Early follow up care creates a continuity of care after a 
hospitalization and allows early intervention if the patient needs help with medication 
titration, diuresis, electrolyte replacement, or further education to aid the patient in their 
ability to manage their disease.       
Many studies have been completed on the need to reduce the readmissions of 
heart failure, but few studies have conclusively determined the interventions necessary to 
accomplish it.  The studies have small sample sizes or produce results that are not 
statistically significant to support their hypotheses.  More qualitative studies need to be 
completed to learn from patients with heart failure where the needs are in terms of 
education and follow up care.  More studies need to be performed to determine how to 
improve patient compliance with diet and medications, as well as keeping their follow up 
appointments.  The impact of this literature review on this scholarly project was to clarify 
the focus of this study which seeks to identify quality improvement measures needed to 
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help reduce the 30-day readmission rate.  Initially, involvement in a heart failure clinic 
shortly after discharge from a hospital was the main idea researched to improve the 
readmission rate.  However, after completing the research and review of literature, the 
intervention must be more complex than simply involvement in a heart failure clinic.  
Standardizing the interventions included in the heart failure clinics, as well as the 
multidisciplinary teams included in these clinics, is one of the first steps needed to make 
a difference in the readmission rates of heart failure patients.    
Gaps in the literature are seen in the shortage of quality studies with large enough 
sample sizes to show a statistically significant correlation between the outcome and 
intervention.  Many of the studies showed positive correlation between involvement in a 
heart failure clinic and decreased readmissions, however the sample sizes were small and 
therefore the data was not statistically significant enough to establish a relation between 



















This quantitative study was designed to determine if follow up appointments at 
heart failure clinics effectively decrease the 30-day hospital readmission rate for heart 
failure patients.  A study was conducted to determine if follow up appointments at the 
AdventHealth heart failure clinic following hospitalizations was an effective way to 
reduce 30-day hospital readmissions.  This chapter covers the methodology, selection and 
protection of subjects, instrumentation, data collection, and analysis of data for this study.   
Project Design 
This study’s project design was a retrospective chart review of heart failure clinic 
patients at the AdventHealth Heart Failure Clinic.  Data was collected on the 30-day 
readmission rate of heart failure patients prior to the opening of the clinic in the fall of 
2015 and compared to the 30-day readmission rate of patients who followed up at the 
clinic after a hospitalization for heart failure.  A total of 429 patient charts were reviewed 
to find 100 charts that met the inclusion criteria for the study.  A list of total patients in 
the AdventHealth heart failure clinic was given to the researcher by AdventHealth.  This 
list was randomized in a Microsoft Excel spreadsheet by using the randomization formula 
and assigning each patient financial identification number (FIN) a random number.  
These random numbers were then sorted in ascending order and the corresponding patient 
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charts were reviewed starting with the first FIN and reviewing charts in order.  No patient 
identifying information was collected or used in this study.    
Sample/Target Population 
The target population for this study was patients at the AdventHealth Heart 
Failure Clinic in Shawnee Mission, Kansas.  Only subjects who were a part of the 
AdventHealth System with an established diagnosis of heart failure and a previous 
hospitalization for heart failure were considered in this study.  A retrospective chart 
review of randomly selected subjects was conducted for data collection.  A goal of 100 
charts were reviewed for the collection of data.       
Inclusion and Exclusion Criteria 
  The inclusion criteria for this project was adult patients ages 18-100 that had 
been hospitalized for heart failure at AdventHealth Shawnee Mission, had a heart failure 
diagnosis since September 2014 or before, and had been a patient of the heart failure 
clinic for at least twelve months. Exclusion criteria for this project included: pediatric 
patients, subjects who did not follow up at the AdventHealth heart failure clinic following 
hospitalization for heart failure, subjects who had been diagnosed with heart failure after 
September 2014, subjects who did not follow up at the clinic for a minimum of 12 
months, death, and/or dialysis.     
Protection of Human Subjects  
The Institutional Review Board (IRB) of Pittsburg State University and the Irene 
Ransom Bradley School of Nursing approved this study based on their requirements 
before data collection was initiated. This study met the requirements for exempted IRB 
status because there was no harm to human subjects. For the protection of the 
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participants, no identifiable demographic information was needed or used in this study.  
There were no risks identified for the human participants.  
Procedures 
Mutual Agreement with Cooperating Agency.   Approval was obtained from 
AdventHealth Shawnee Mission to do a retrospective chart review on patients that were 
seen at the heart failure clinic following a hospitalization for heart failure.  The chart 
audit looked at 30-day readmission rates for heart failure before the opening of the clinic 
and the 30-day readmission rates after follow-up visits at the clinic.  Approval letters 
were obtained from Amber Delphia, Clinical Education Specialist and Student Liaison for 
AdventHealth Shawnee Mission and Andrea Stafos, former chair for the Council for 
Research and Evidence Based Practice and AdventHealth Shawnee Mission, both via 
email. 
Timeline 
  Data collection began January 6, 2020 and was completed March 13, 2020.  
After data was collected, it was evaluated, and results were completed on March 20, 
2020. 
Resources Needed  
The technology needed for this project included the technology needed to access 
charts of the subjects and evaluate the data.  The human resources needed were the author 
and person completing the chart reviews.  
Market analysis 
This study hopefully showed the effectiveness of a heart failure clinic at reducing 
30-day hospital readmissions as well as an improved or stable EF, GFR, hemoglobin A1c, 
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and BMI.  If this study showed the heart failure clinic was successful at reducing 30-day 
readmissions for heart failure, it could significantly decrease overall healthcare costs 
associated with heart failure as well as decrease mortality rates.  This study could also 
provide evidence to support the updating of current clinical practice for hospitalized heart 
failure patients to include follow up appointments at heart failure clinics as well as 
support the need for an increase in the number of heart failure clinics.  The results of this 
study were presented to the head of the AdventHealth Heart Failure Clinic.  These results 
hopefully supported the work that has been put into establishing the clinic.     
Outcome Data 
The outcome data collected was the number of 30-day hospital admissions for 
heart failure and patient compliance with follow up visits at the heart failure clinic.  This 
data was used to determine if follow up visits at the heart failure clinic were effective at 
reducing the 30-day readmission rate for heart failure patients.  
Tools/Instruments 
Data collected was evaluated using the paired samples t-test.  The means of each 
group was calculated and compared.  The subject groups were divided up into pre and 
post groups.  Group 1 (pre-clinic) was composed of data collected before the heart failure 
clinic was established and Group 2 (post-clinic) will be composed of data collected after 
establishing care at the heart failure clinic.  (See Appendix 1) 
Methods of Analysis 
Data was analyzed using the paired samples t-test and the Wilcoxon Signed Ranks 
Test.  The readmission rate means of the two sample groups were compared to determine 
if there was a statistical significance that correlated follow up visits at the heart failure 
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clinic to a decrease in 30-day hospital readmission rates.  Data collected regarding 
hemoglobin A1c, EF, GFR, and BMI was also be compared to determine if the heart 
failure clinic had prevented any worsening of these values.  Data regarding pro-BNP 
levels were also collected however, during the collection of this data it was found that no 
follow up pro-BNP levels were collected after the initial one drawn upon admission for a 
heart failure exacerbation.  This data was excluded from the study due to the 
inconsistency of when and how often this lab was drawn.       
Strengths and Weakness of the Study 
The strengths of the study were using the same patients as the pre-clinic and post-
clinic groups as well as the randomization of the charts that were reviewed.  Weaknesses 
of the study included human error, the possibility the patients were diagnosed with heart 
failure at a different hospital prior to being diagnosed at AdventHealth, and the 
inconsistency of the frequency that data was collected as well as the type of data 
collected.  To strengthen future studies like this, standards could be created for heart 

























The purpose of this study was to determine if follow up visits at the AdventHealth 
heart failure clinic in Shawnee Mission, Kansas were effective in reducing the 30-day 
readmission rate of heart failure patients.  A retrospective chart review was done to 
collect pre-clinic and post-clinic data on 100 patients which met the inclusion criteria of 
the study.  The project questions evaluated include:  
1. Will patients who received care at a heart failure clinic have reduced 30-day 
readmission rates versus those who did not receive care at a heart failure 
clinic? 
2. Will patient’s EF, hemoglobin A1c, GFR, and BMI remain stable or improve 
as a result of heart failure clinic visits? 
Description of Population  
The demographic characteristics of the population sampled include 58 males and 
42 females (Table 2) with a current age range of 41 to 99 (Table 3).  Patients followed up 
at the AdventHealth heart failure clinic from 1 to 5 years with 34 percent following up for 
5 years (Table 4).  Upon approval from the Pittsburg State University research committee, 
AdventHealth Shawnee Mission, and IRB; data were collected between January 1, 2020, 
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and March 13, 2020.  Inclusion criteria was adult patients ages 18-100 that had been 
hospitalized for heart failure at AdventHealth Shawnee Mission, had a heart failure 
diagnosis since September 2014 or before, and had been a patient of the heart failure 
clinic for at least twelve months. Pediatric patients, patients who did not follow up at the 
AdventHealth heart failure clinic following hospitalization for heart failure, patients who 
had been diagnosed with heart failure after September 2014, patients who did not follow 
up at the clinic for a minimum of 12 months, patients who died prior to completing 12 
months at the heart failure clinic, and patients on dialysis were not included in the data 
collected.  The demographic data was divided into age of diagnosis, current age, years at 
the heart failure clinic, gender, number of 30-day hospital readmissions pre and post-
clinic, GFR pre and post-clinic, EF pre and post-clinic, A1c pre and post-clinic, and BMI 
pre and post-clinic.  This chapter will review the data tables and statistical findings of the 
data collected.  Data analysis was performed using SPSS and the comparison between the 
pre and post measures were conducted using the paired samples t-test and the Wilcoxon 
Signed Ranks Test.  
Table 2.  Gender 
 Frequency Percent 
Male 58 58.0 
Female 42 42.0 







Table 3.  Population Ages at Diagnosis and Current Age  
 
Age Groups in 
Years 
Age at diagnosis Current Age 
 Freq. Percent Freq. Percent 
40 and less 2 2.0 0 0.0 
41-45 1 1.0 2 2.0 
46-50 3 3.0 0 0.0 
51-55 5 5.0 2 2.0 
56-60 13 13.0 5 5.0 
61-65 13 13.0 7 7.0 
66-70 13 13.0 10 10.0 
71-75 15 15.0 13 13.0 
76-80 14 14.0 14 14.0 
81-85 11 11.0 15 15.0 
86-90 9 9.0 12 12.0 
91 and up 1 1.0 20 20.0 
 
Table 4.  Years at Clinic 
 Frequency Percent 
1 4 4.0 
2 18 18.0 
3 17 17.0 
4 27 27.0 
5 34 34.0 
Total 100 100.0 
 
Analysis of Project Questions  
Data were collected to determine if appointments at a heart failure clinic 
(specifically the AdventHealth heart failure clinic) following hospitalization for heart 
failure, reduces the 30-day readmission rate for heart failure.  The data collected 
determined if the patient’s EF, hemoglobin A1c, GFR, and BMI remained stable or 
improve as a result of those heart failure clinic visits or if they declined.   
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Research Question One.  Did patients who received care at a heart failure clinic 
have reduced 30-day readmission rates versus those who did not receive care at a heart 
failure clinic?  The number of 30-day hospital readmissions was counted from the year of 
diagnosis to the opening of the heart failure clinic and then from the opening of the heart 
failure clinic through March 13, 2020 and entered into the data collection tool for each 
subject included in the study (Table 5).  Tables 6 and 7 show the statistics calculated.   
Table 5.  Number of 30-day Readmissions 
Number of 30-day Readmissions   
 Pre-clinic Post-clinic 
 Frequency Percent Frequency Percent 
0 61 61.0 62 62.0 
1 14 14.0 26 26.0 
2 11 11.0 8 8.0 
3 7 7.0 1 1.0 
4 4 4.0   
5 1 1.0   
6   2 2.0 
7   1 1.0 
8 1 1.0   




Number of 30-day Readmissions Pre-clinic 1.01 2.002 
Number of 30-day Readmissions Post-clinic .64 1.219 
 
Table 6.  Paired Samples Statistics 30-day Readmissions 
 Mean N 
Std. 
Deviation Std. Error Mean 
Pair 
1 
Number of 30-day Readmissions 
Pre-clinic 
1.01 100 2.002 0.200 
Number of 30-day Readmissions 
Post-clinic 
0.64 100 1.219 0.122 
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Pair 1 Number of 30-day 
Readmissions Pre-clinic - 
Number of 30-day 
Readmissions Post-clinic 
0.370 1.790 2.067 99 0.041 
 
There was a statistically significant difference between 30-day hospital readmissions 
when comparing pre-clinic readmissions and post-clinic readmissions (t = 2.06, p = .041). 
The difference found was 0.37 times less 30-day hospital readmissions post-clinic.  
Research Question Two.  Did the patient’s EF, GFR, hemoglobin A1c, and BMI 
remain stable or improve as a result of heart failure clinic visits?  The EF, GFR, A1c, and 
BMI were collected at diagnosis or as close to diagnosis as was available (pre-clinic) as 
well as the most recent numbers available (post-clinic).  Data collected were entered into 
tables and are shown in Tables 8 to 19 with the statistics below.  The statistics were 











Table 8.  Ejection Fraction (EF) 
 
 EF Pre-clinic EF Post-clinic 
Ranges of EF Frequency Percent Frequency Percent 
10-15 3 3.0   
16-20 2 2.0 6 6.0 
21-25 4 4.0 11 11.0 
26-30 8 8.0 7 7.0 
31-35 3 3.0 10 10.0 
36-40 11 11.0 6 6.0 
41-45 15 15.0 12 12.0 
46-50 10 10.0 7 7.0 
51-55 12 12.0 8 8.0 
56-60 24 24.0 16 16.0 
61-65 8 8.0 13 13.0 
66 and higher   4 4.0 
The EF values collected ranged from 10 to greater than 66.  These values were 
changed into ranges and the frequency of each range was calculated.  A Wilcoxon 
statistic was used to calculate if the EF post-clinic was equal to the EF pre-clinic values.  
These values are provided in Table 8 and Table 9.  There was not a statistically 
significance difference between the pre- and post-clinic values for EF (Wilcoxon = -1.38, 
p = .181).  
 
Table 9.  EF Wilcoxon Statistics 
Ranks N Mean Rank Sum of Ranks 
EF Post Clinic - EF Pre 
Clinic 
Negative Ranks 36a 44.22 1592.00 
Positive Ranks 37b 29.97 1109.00 
Ties 27c   
Total 100   
a. EF Post Clinic < EF Pre Clinic 
b. EF Post Clinic > EF Pre Clinic 







Table 10.  Wilcoxon Test Statistics 
 EF Post Clinic - EF Pre Clinic 
Wilcoxon Statistic -1.338b 
Asymp. Sig. (2-tailed) .181 
a. Wilcoxon Signed Ranks Test 
b. Based on positive ranks. 
 
Table 11.  GFR Pre and Post-clinic 
 GFR Pre-clinic GFR Post-clinic 
GFR Range Frequency Percent Frequency Percent 
20 or less 3 3.0 10 10.0 
21-30 5 5.0 8 8.0 
31-40 5 5.0 17 17.0 
41-50 16 16.0 19 19.0 
51-60 22 22.0 12 12.0 
61-70 13 13.0 10 10.0 
71-80 7 7.0 10 10.0 
81-90 13 13.0 9 9.0 
91-100 8 8.0   
101-110 5 5.0 4 4.0 
111 and greater 3 3.0   
Missing Data   1 1.0 
Table 12.  GFR Paired Samples Statistics 
 Mean N Std. Deviation Std. Error Mean 
Pair 1 GFR Pre Clinic 64.4414 99 24.20361 2.43255 






Table 13.  Paired Samples Test 
 
  







GFR Pre Clinic - GFR 
Post Clinic 
12.57778 25.69821 4.870 98 .000 
 
There was a statistical difference that showed the GFR post-clinic was 12.58 less than the GFR 
pre-clinic (t = 4.87, p = .000).  The mean pre-clinic GFR was 64.76 and the mean GFR 
post-clinic was 51.86.  
  
Table 14.  Hemoglobin A1c Pre- and Post-clinic 
 A1c Pre-clinic A1c Post-clinic 
A1c Range Frequency Percent Frequency Percent 
4.0-4.9 5 5.0 7 7.0 
5.0-5.9 38 38.0 38 38.0 
6.0-6.9 22 22.0 26 26.0 
7.0-7.9 14 14.0 7 7.0 
8.0-8.9 3 3.0 8 8.0 
9.0-9.9 5 5.0 3 3.0 
10.0-10.9     
11.0-11.9     
12.0-12.9 2 2.0   
13.0 and greater 2 2.0 2 2.0 
Missing Data 9 9.0 9 9.0 
Table 15.  Hemoglobin A1c Paired Samples Statistics 
 Mean N Std. Deviation Std. Error Mean 
Pair 1 A1c Pre-clinic 6.6604 91 1.84233 .19313 

















A1c Pre-clinic - A1c 
Post-clinic 
.20879 1.83791 1.084 90 .281 
 
There was no statistical difference between the A1c pre-clinic and A1c post-clinic.  The 
mean pre-clinic A1c was 6.7 and the mean post-clinic A1c was 6.5.   
 
Table 17.  BMI Pre and Post-clinic 
 BMI Pre-clinic BMI Post-clinic 
BMI Range Freq. % Freq % 
20 or less 2 2.0 6 6.0 
21-25 21 21.0 36 36.0 
26-30 30 30.0 23 23.0 
31-35 20 20.0 14 14.0 
36-40 17 17.0 13 13.0 
41-45 6 6.0 5 5.0 
46 and greater 4 4.0 2 2.0 
 
Table 18.  BMI Paired Samples Statistics 
 
 Mean N Std. Deviation Std. Error Mean 
Pair 1 BMI Pre-clinic 31.4527 100 7.37664 .73766 





















BMI Pre-clinic - BMI Post-clinic 1.93060 4.99364 3.866 99 .000 
The BMI post-clinic was 1.93060 less than the BMI pre-clinic.  This difference was 
statistically significant (t = 3.866, p = .000).  The mean pre-clinic BMI was 31.5 and the 



























The specific purpose of this project was to evaluate the efficiency of the 
AdventHealth heart failure clinic in Shawnee Mission, Kansas at reducing the 30-day 
hospital readmission rate of heart failure patients.  It was also to determine if a patient’s 
BMI, EF, GFR, and A1c would improve or remain stable with follow-up appointments at 
the same clinic or if they would worsen.  Improvement or stability in a patient’s EF, GFR, 
A1c, and BMI would indicate the patients’ overall health is improving or stable.  This 
study was to determine if heart failure clinics can be an effective way for hospitals to 
reduce the 30-day readmissions of heart failure patients and improve reimbursements 
from Medicare.  
Relationship of Outcomes to Research  
Two research questions were examined in this project.  The first question was 
“does the AdventHealth heart failure clinic lower the 30-day readmission rate for heart 
failure patients who follow up there after hospitalizations for heart failure?”  This 
question was answered by completing a retrospective chart review and comparing the 
number of 30-day readmissions before the opening of the AdventHealth heart failure 
clinic in September 2015 with the number of 30-day readmissions after following up at 
41 
 
the clinic.  The study proved there was a statistically significant difference between 30-
day hospital readmissions when comparing pre-clinic readmissions and post-clinic 
readmissions. The statistics showed post-clinic patients were readmitted within 30-days 
of a previous hospitalization for heart failure 0.37 times less than pre-clinic patients.  The 
clinic was effective at reducing the 30-day readmission rate of heart failure patients.   
The second question was “did patient’s EF, GFR, hemoglobin A1c, and BMI 
remain stable or improve as a result of heart failure clinic visits?”  This question had 4 
different parts to it.  First, did the EF improve or remain stable?  The way an EF was 
reported in the charting was not consistent.  At times it was reported as a single number 
and other times it was reported as a range.  In order to be as consistent and concise as 
possible, the data was placed into 12 ranges.  All ranges reported were placed in the range 
with the highest EF reported, for example a reported EF of 45-50 was placed in the 46-50 
range for data reporting.  This was done to provide consistency.  Since the data being 
reported was in a range, a paired samples t-test was not able to be conducted and 
therefore a Wilcoxon Statistics test was run and showed that post-clinic EFs were the 
same or better than the pre-clinic EFs.  Of the 100 charts reviewed, 37 of the post-clinic 
EFs were better than the pre-clinic EFs and 27 of the post-clinic EFs were the same as the 
pre-clinic EFs.  This left 36 post-clinic EFs less than (or worse) pre-clinic EFs.   
The second variable examined in the second question was did the GFR improve 
or remain stable?  A paired samples t-test was also used to determine if the GFR was 
improved or stable.  There was a statistical significance that showed the GFR post-clinic 
was 12.58 less than the GFR pre-clinic.  The mean pre-clinic GFR was 64.76 and the 
mean GFR post-clinic was 51.86.  These results showed a worsening of the GFR with 
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post-clinic samples.  There are many different things that can lower a patient’s GFR. This 
could be seen as the heart failure clinic not helping to overall improve the patient 
outcomes; however, it also could be explained as GFR and overall kidney function 
worsening over time as well as something commonly seen in patients with comorbidities.   
The third variable examined in the second question was did the hemoglobin A1c 
improve or remain stable?   A paired samples t-test was used to determine if the A1c was 
improved or stable.  There was no statistical significance difference between the A1c pre-
clinic and A1c post-clinic.  The mean pre-clinic A1c was 6.7 and the mean post-clinic 
A1c was 6.5.  These values were similar however, there was no statistical significance to 
show the clinic was effective at improving a patient’s A1c.  There were 9 charts reviewed 
pre-clinic and post-clinic that were missing data.  This was not enough to skew the 
results.     
The fourth variable examined in the second question was did the BMI improve or 
remain stable?   A paired samples t-test was used to determine if the BMI was improved 
or stable.  There was statistical significance difference to show the BMI post-clinic was 
1.93 less than the BMI pre-clinic.  The mean pre-clinic BMI was 31.5 and the mean post-
clinic BMI was 29.5.  The BMI was collected to determine if patients were able to 
maintain their weight or even lose weight due to following a low sodium diet.      
Observations  
General observations noted during the collection of data were the differences in 
reporting of EF from each physician reading the echocardiogram.  Another difference 
noted was the frequency of obtaining a patient’s BMI, A1c, EF, and GFR.  The GFR was 
obtained at each visit, however the BMI was only obtained during hospitalizations.  The 
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A1c and EF were only obtained when the physician determined it was necessary.  There 
were 9 subjects who never had their A1c checked from the time of their diagnosis to 
current day.   
Evaluation of Theoretical Framework  
The findings support the Uncertainty in Illness Theory, specifically that patients 
will do their best to obtain as much information to minimize the uncertainty they have 
with a chronic illness.  This was shown in that patients who followed up at the heart 
failure clinic had fewer 30-day readmissions for heart failure.  These heart failure clinic 
appointments were used to closely monitor and follow up with patients to lessen the 
uncertainty faced by these patients with heart failure.  Clinic appointments would help 
provide strategies to increase patient engagement and interest in self-care.  The more 
engaged and involved patients are with their own health, the better the outcomes may be. 
Evaluation of Logic Model  
The logic model for this scholarly project (Figure 2) was created to show the 
relationships between the inputs, outputs, and outcomes as well as the assumptions and 
external factors involved in this study.  Regarding the short-term outcomes of this study, 
this researcher was able to obtain an increased knowledge of the heart failure clinical 
practice guidelines and a better understanding of heart failure and what is needed to 
prevent readmissions.  Regarding the intermediate outcomes of this study, it was found 
that the current number of patients seen in the clinic is over 1400.  The clinical notes in 
the individual patient charts written by the nurse practitioner who provided the care 
showed an increase in the medication compliance with the heart failure clinic patients 
based on patients verbalizing their compliance when asked.  Regarding the long-term 
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outcomes of this study, the 30-day readmissions for heart failure were statistically 
significantly decreased when compared to the 30-day readmissions before the clinic 
opened.     
 
Limitations  
There were some limitations found in the completion of this study.  While there 
was no sampling bias due to the randomization of the population to be sampled, some 
patients could have been excluded due to their initial diagnosis of heart failure being done 
at a different hospital.  Many patients fail to self-report much of their health history and a 
failure of their self-reporting a previous diagnosis could mean some patients were 
unintentionally excluded.  Another limitation of the study was the inconsistency of how 
and when different physicians order diagnostic and laboratory tests.  One last limitation 
was the inconsistency in how and when a patient’s pro-BNP was ordered.  The pro-BNP 
was one way used to determine if a patient was in an exacerbation of heart failure.  
During the data collection it was found that the BNP was only collected upon initial 
admission for a heart failure exacerbation.  No follow up BNPs were collected to 
determine how the patient’s fluid overload status was improving.  Therefore, this variable 
was removed from the study.    
Implications for Future Projects and Research  
Heart failure clinics are an excellent way to help heart failure patients receive 
closer monitoring and reduce 30-day readmissions for heart failure.  The efficiency of 
these clinics on their ability to reduce 30-day readmissions is something that has not been 
studied in detail.  This study pointed out some limitations and improvements that could 
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be made in future studies and pointed out a need for further studies like this.  This study 
also showed that heart failure clinics are beneficial in reducing the 30-day readmission 
rate for heart failure patients and should be utilized more frequently to maximize 
reimbursements from Medicare.  
Future studies should be completed with larger sample sizes and include variables 
such as race, medication compliance, diet compliance, and qualitative data like overall 
understanding of heart failure and patient view on the benefits of the clinic.  This would 
provide data on what heart failure clinics could add to how they treat patients to make 
them more successful at improving patients’ lives in decreasing their morbidity and 
mortality.    
Implications for Practice 
The results of this study showed that the AdventHealth heart failure clinic was 
effective at reducing the 30-day readmission rate for heart failure patients.  The 
implications for practice are that these clinics should be made more available and utilized 
with every heart failure patient after every hospital admission for heart failure.  This 
study also pointed out areas of current practice that could be changed and streamlined so 
all physicians provided the same care for each patient each time, for example when 
providers order diagnostic tests and laboratory tests.     
Conclusion  
Many studies have been completed on the need to reduce the readmissions of 
heart failure, but few studies have determined interventions to accomplish it.  Current 
studies have small sample sizes or produce results that are not statistically significant to 
support their hypotheses.  This study had a large enough sample size that was able to 
46 
 
produce statistically significant data.  The data collected showed the AdventHealth heart 
failure clinic was a successful way to reduce the 30-day readmission rate of heart failure 
patients.   
Not only were the 30-day hospital readmissions reduced after the initiation of the 
AdventHealth heart failure clinic, the patients had a lower BMI and increased EF after 
following up and the heart failure clinic when comparted to their BMI and EF before the 
opening of the clinic.  These variables demonstrated that the heart failure clinic helped to 
improve the patient outcomes.  From 2007 to 2009, a review of Medicare claims showed 
that 35% of all 30-day hospital readmissions were for heart failure (Feltner et al., 2014).  
With the use of heart failure clinics like the AdventHealth heart failure clinic, 35% of 30-
day readmissions could potentially be prevented and that would mean a potential savings 
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Instrument for Data Collection 
 
Patient Number (1-100) 
Age at diagnosis  
Current Age  
Years at clinic  
Gender (M/F)  
Number of 30-Day Readmissions Pre-clinic  
Number of 30-Day Readmissions Post-clinic 
Ejection Fraction Pre-clinic  
Ejection Fraction Post-clinic  
GFR Pre-clinic  
GFR Post-clinic  
BMI Pre-clinic  
BMI Post-clinic  
Hemoglobin A1c Pre-clinic  
Hemoglobin A1c Post-clinic  
BNP Pre-clinic  
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